“The outcome will be injected back into the body where these dendritic cells are expected to trigger other immune cells to form an immune memory to defend against SARS CoV-2,” Terawan explained.
He hopes that with the publication of the international Q1 journal, the Nusantara vaccine can advance the health science internationally, and provide solution to the Covid-19 pandemic around the world.
Read: ASEAN countries will mutually recognize each other’s Covid-19 vaccine certificates
He also expressed his gratitude to the government, President Joko Widodo, Kariadi Hospital Semarang, RSPAD Gatot Subroto that he said have supported the Nusantara vaccine research and development.